Skip to content

Effect of Tranexamic Acid on Infammatory Reaction and Antifibrinolysis in Severe Elbow Stiffness Patients

Effect of Tranexamic Acid on Infammatory Reaction and Antifibrinolysis in Severe Elbow Stiffness Patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037211
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-08-18
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-trauma severe elbow stiffness

Interventions

Group 1:Intra-Articular Tranexamic Acid 1g
Group 2:Intravenous Tranexamic Acid 1g
Group 3:Intravenous 1g and Intra-Articular Tranexamic Acid 1g plus

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) no regaining a functional arc of motion from 6 months of nonoperative treatment; (2) severe elbow stiffness (defined as ROM <= 60 degrees according to the classification proposed by Mansat and Morrey.

Exclusion criteria

Exclusion criteria: (1) known allergy to TXA; (2) preoperative hemoglobin of less than 100 g/L; (3) known bleeding disorders; (4) concomitant severe comorbidities (renal failure, serious pulmonary disease, myocardial infarction, coronary disease, myocardial infarction, previous thrombosis); (5) associated with nonunion or malunion of elbow; (6) associated with burns or central nervous system trauma; (7) previous operation history of internal fixation or open release in the affected elbow side.

Design outcomes

Primary

MeasureTime frame
Inflammatory index;

Secondary

MeasureTime frame
?brinolysis index;Swelling of elbow joint;Pain at rest;pain on motion;Analgesic dosage;

Countries

China

Contacts

Public ContactCunyi Fan

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

cyfan@sjtu.edu.cn+86 15588827972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026